Human Pathology
Volume 34, Issue 10 , Pages 1030-1034 , October 2003

Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes

  • Laurentia Nodit, MD

      Affiliations

    • Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    • ,
  • David W Bahler, MD, PhD

      Affiliations

    • Department of Pathology, University of Utah, Salt Lake City, UT, USA
    • ,
  • Samuel A Jacobs, MD

      Affiliations

    • Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
    • ,
  • Joseph Locker, MD, PhD

      Affiliations

    • Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA
    • ,
  • Steven H Swerdlow, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint requests to Steven H. Swerdlow, MD, Department of Pathology, Division of Hematopathology, UPMC Presbyterian—Room C606, 200 Lothrop Street, Pittsburgh, PA 15213, USA
    • Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

,Accepted 5 June 2003.

References 

  1. Banks PM, Chan J, Cleary ML, et al.  Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992;16:637–640
  2. Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol. 1999;36:115–127
  3. Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma (A clinicopathologic and molecular review of 3 decades). Hum Pathol. 2002;33:7–20
  4. Hummel M, Tamaru J, Kalvelage B, et al.  Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood. 1994;84:403–407
  5. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood. 1997;89:3909–3918
  6. Swerdlow SH, Berger F, Issacson PG, et al.  Mantle cell lymphoma. In:  Jaffe ES,  Harris NL,  Stein H, et al. editor. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC; 2001;p. 168–170
  7. Zucca E, Stein H, Coiffier B. European Lymphoma Task Force (ELTF) (Report of the workshop on mantle cell lymphoma (MCL)). Ann Oncol. 1994;5:507–511
  8. Walsh SH, Thorselius M, Johnson A, et al.  Mutated VH genes and preferential VH3–21 use define new subsets of mantle cell lymphoma. Blood. 2003;101:4047–4054
  9. Thorselius M, Walsh S, Eriksson I, et al.  Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol. 2002;68:217–224
  10. Du MQ, Diss TC, Xu CF, et al.  Ongoing immunoglobulin gene mutations in mantle cell lymphomas. Br J Haematol. 1997;96:124–131
  11. Laszlo T, Nagy M, Kelenyi G, et al.  Immunoglobulin V(H) gene mutational analysis suggests that blastic variant of mantle cell lymphoma derives from different stages of B-cell maturation. Leuk Res. 2000;24:27–31
  12. Pittaluga S, Tierens A, Pinyol M, et al.  Blastic variant of mantle cell lymphoma shows a heterogenous pattern of somatic mutations of the rearranged immunoglobulin heavy chain variable genes. Br J Haematol. 1998;102:1301–1306
  13. Graham Osicer D, Rosenwald A, Orchard JA, et al.  DNA microarray analysis distinguishes t(11;14) lymphocytosis from chronic lymphocytic leukemia. Blood. 2002;100:140a–141a
  14. King BE, Chen C, Locker J, et al.  Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol. 2000;13:1219–1231
  15. Chen CC, Raikow RB, Sonmez-Alpan E, et al.  Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. Appl Immunohistochem Mol Morphol. 2000;8:1–11
  16. Bahler DW, Miklos JA, Swerdlow SH. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood. 1997;89:3335–3344
  17. Lardelli P, Bookman MA, Sundeen J, et al.  Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol. 1990;14:752–763
  18. Swerdlow SH, Habeshaw JA, Murray LJ, et al.  Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol. 1983;113:181–197
  19. Tolksdorf G, Stein H, Lennert K. Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br J Cancer. 1980;41:168–182
  20. Hofmann WK, de Vos S, Tsukasaki K, et al.  Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray. Blood. 2001;98:787–794
  21. Zhu Y, Hollmen J, Raty R, et al.  Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma. Br J Haematol. 2002;119:905–915
  22. Garand R, Orchard JA, Davis Z, et al.  A subset of mantle cell lymphoma exhibits stable disease and correlates with mutated VH genes and low CD38 expression. Blood. 2001;98:724a
  23. Kienle DL, Kroeber A, Leupolt E, et al.  VH mutation status and gene usage in mantle cell lymphoma (Correlation with genomic aberrations and survival). (abst) Blood. 2002;100:90a
  24. Andersen NS, Donovan JW, Borus JS, et al.  Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease. Blood. 1997;90:4212–4221
  25. Rosenwald A, Alizadeh AA, Widhopf G, et al.  Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639–1647
  26. Klein U, Tu Y, Stolovitzky GA, et al.  Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194:1625–1638
  27. Segal GH, Masih AS, Fox AC, et al.  CD5-expressing B-cell non-Hodgkin’s lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood. 1995;85:1570–1579
  28. Gaal K, Chen W, Chen YY, et al.  Immunoglobulin heavy chain variable region (VH) mutation in peripheral blood B-cell chronic lymphoproliferative disorders (Variability of somatic mutations between leukemic mantle cell lymphomas and t(11;14) positive cases with prolymphocytic features). Mod Pathol. 2002;15:241a; (abst)
  29. Avet-Loiseau H, Garand R, Gaillard F, et al.  Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosomes Cancer. 1998;23:175–182
  30. Ruchlemer R, Wotherspoon AC, Brito-Babapulle V, et al.  B-prolymphocytic leukemia (B-PLL) revisited-the significance of t(11;14). Blood. 2002;100:569a; (abst)
  31. Schlette E, Bueso-Ramos C, Giles F, et al.  Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001;115:571–581
  32. Wong KF, So CC, Chan JK. Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia. Am J Clin Pathol. 2002;117:246–251
  33. Bahler DW, Aguilera NS, Chen CC, et al.  Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types. Am J Pathol. 2000;157:1063–1070
  34. Liu Z, Dong HY, Gorczyca W, et al.  CD5− mantle cell lymphoma. Am J Clin Pathol. 2002;118:216–224
  35. Kaptain S, Zukerberg LR, Ferry JA, et al.  BCL-1 cyclin D1+CD5− mantle cell lymphoma. Mod Pathol. 1998;11:133A; (abst)
  36. Cong P, Raffeld M, Teruya-Feldstein J, et al.  In situ localization of follicular lymphoma (Description and analysis by laser capture microdissection). Blood. 2002;99:3376–3382
  37. Rawstron AC, Green MJ, Kuzmicki A, et al.  Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100:635–639

PII: S0046-8177(03)00410-6

doi: 10.1053/S0046-8177(03)00410-6

Human Pathology
Volume 34, Issue 10 , Pages 1030-1034 , October 2003

Article Tools

* Image Usage & Resolution